Cellectis (CLLS) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $1.04, -5.88% vs the prior close of $1.11.
- Volume 81.36K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CLLS slides 5.9% to $1.04, a 52-week low. Closed at $1.04, -5.88% vs the prior close of $1.11. Day range $1.03β$1.12, opened at $1.12.
CLLS daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β CLLS slides 5.9% to $1.04, a 52-week low
- Closed at $1.04, -5.88% vs the prior close of $1.11. Day range $1.03β$1.12, opened at $1.12.
- Volume was 81.36K shares, 0.8x its 50-day average of 106.58K.
- Price is -54.6% vs its 50-day average ($2.29) and -67.9% vs its 200-day average ($3.24).
- 52-week range $1.03β$5.48; today's close sits at 0% of that range, 81.0% below the 52-week high.
Oct 15, 2026 β CLLS dips 1.3% to $1.11
- Closed at $1.11, -1.34% vs the prior close of $1.12. Day range $1.09β$1.14, opened at $1.14.
- Volume was 101.10K shares, 1.0x its 50-day average of 104.64K.
- Price is -52.4% vs its 50-day average ($2.32) and -66.1% vs its 200-day average ($3.26).
- 52-week range $1.09β$5.48; today's close sits at 0% of that range, 79.8% below the 52-week high.
Oct 14, 2026 β CLLS rises 1.8% to $1.12
- Closed at $1.12, +1.82% vs the prior close of $1.10. Day range $1.10β$1.15, opened at $1.12.
- Volume was 99.10K shares, 1.0x its 50-day average of 103.09K.
- Price is -52.5% vs its 50-day average ($2.36) and -65.8% vs its 200-day average ($3.28).
- 52-week range $1.09β$5.48; today's close sits at 1% of that range, 79.6% below the 52-week high.
Oct 13, 2026 β CLLS slides 6.8% to $1.10, a 52-week low
- Closed at $1.10, -6.78% vs the prior close of $1.18. Day range $1.09β$1.17, opened at $1.17.
- Volume was 54.20K shares, 0.5x its 50-day average of 102.07K β lighter than usual.
- Price is -54.0% vs its 50-day average ($2.39) and -66.6% vs its 200-day average ($3.30).
- 52-week range $1.09β$5.48; today's close sits at 0% of that range, 79.9% below the 52-week high.
Oct 12, 2026 β CLLS slides 6.3% to $1.18, a 52-week low
- Closed at $1.18, -6.35% vs the prior close of $1.26. Day range $1.14β$1.28, opened at $1.25.
- Volume was 122.60K shares, 1.2x its 50-day average of 99.87K.
- Price is -51.3% vs its 50-day average ($2.42) and -64.4% vs its 200-day average ($3.32).
- 52-week range $1.14β$5.48; today's close sits at 1% of that range, 78.5% below the 52-week high.
Oct 9, 2026 β CLLS rises 0.8% to $1.26
- Closed at $1.26, +0.80% vs the prior close of $1.25. Day range $1.25β$1.29, opened at $1.27.
- Volume was 75.80K shares, 0.8x its 50-day average of 98.43K.
- Price is -48.7% vs its 50-day average ($2.45) and -62.2% vs its 200-day average ($3.33).
- 52-week range $1.22β$5.48; today's close sits at 1% of that range, 77.0% below the 52-week high.
Oct 8, 2026 β CLLS slides 6.7% to $1.25, a 52-week low, 4 down days in a row
- Closed at $1.25, -6.72% vs the prior close of $1.34. Day range $1.22β$1.31, opened at $1.28.
- Volume was 106.80K shares, 1.1x its 50-day average of 96.49K.
- Price is -49.7% vs its 50-day average ($2.49) and -62.7% vs its 200-day average ($3.35).
- 52-week range $1.22β$5.48; today's close sits at 1% of that range, 77.2% below the 52-week high.
- That makes 4 straight losses.
Oct 7, 2026 β CLLS slides 4.3% to $1.34, a 52-week low, 3 down days in a row
- Closed at $1.34, -4.29% vs the prior close of $1.40. Day range $1.33β$1.40, opened at $1.35.
- Volume was 62.50K shares, 0.7x its 50-day average of 95.55K.
- Price is -46.8% vs its 50-day average ($2.52) and -60.2% vs its 200-day average ($3.37).
- 52-week range $1.25β$5.48; today's close sits at 2% of that range, 75.5% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 β CLLS dips 0.7% to $1.40
- Closed at $1.40, -0.71% vs the prior close of $1.41. Day range $1.37β$1.44, opened at $1.42.
- Volume was 75.80K shares, 0.8x its 50-day average of 94.10K.
- Price is -45.1% vs its 50-day average ($2.55) and -58.6% vs its 200-day average ($3.38).
- 52-week range $1.25β$5.48; today's close sits at 4% of that range, 74.5% below the 52-week high.
Oct 5, 2026 β CLLS dips 1.4% to $1.41
- Closed at $1.41, -1.40% vs the prior close of $1.43. Day range $1.38β$1.44, opened at $1.43.
- Volume was 37.30K shares, 0.4x its 50-day average of 93.83K β lighter than usual.
- Price is -45.3% vs its 50-day average ($2.58) and -58.5% vs its 200-day average ($3.39).
- 52-week range $1.25β$5.48; today's close sits at 4% of that range, 74.3% below the 52-week high.
Oct 2, 2026 β CLLS rises 2.1% to $1.43
- Closed at $1.43, +2.14% vs the prior close of $1.40. Day range $1.42β$1.47, opened at $1.45.
- Volume was 46.80K shares, 0.5x its 50-day average of 93.07K β lighter than usual.
- Price is -45.1% vs its 50-day average ($2.61) and -58.0% vs its 200-day average ($3.41).
- 52-week range $1.25β$5.48; today's close sits at 4% of that range, 73.9% below the 52-week high.
CLLS latest news & SEC filings
Every SEC filing by or about CLLS in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 14, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 11, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Sep 11, 2026 Β· Form 6-K/A β 6-K/A filing
6-K/A filing
Sep 1, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 6, 2026 Β· Form S-8 β Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 6, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 6, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 30, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 26, 2026 Β· Form 6-K/A β 6-K/A filing
6-K/A filing
Jun 25, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jun 25, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade CLLS
- How much it moves: over the last 20 sessions the average daily move was 3.27% (largest 7.7%). That is a volatile stock.
- Liquidity: about 80.19K shares (β$83.40K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $1.04 vs a range of $1.03β$5.48 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 6-K Sep 14, 2026; 6-K Sep 11, 2026; 6-K Sep 1, 2026.
- Listing: Nasdaq Β· industry: Biological Products, (No Diagnostic Substances).
CLLS market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 1.12 | 1.12 | 1.03 | 1.04 | 81.36K |
| Oct 15, 2026 | 1.14 | 1.14 | 1.09 | 1.11 | 101.10K |
| Oct 14, 2026 | 1.12 | 1.15 | 1.10 | 1.12 | 99.10K |
| Oct 13, 2026 | 1.17 | 1.17 | 1.09 | 1.10 | 54.20K |
| Oct 12, 2026 | 1.25 | 1.28 | 1.14 | 1.18 | 122.60K |
| Oct 9, 2026 | 1.27 | 1.29 | 1.25 | 1.26 | 75.80K |
| Oct 8, 2026 | 1.28 | 1.31 | 1.22 | 1.25 | 106.80K |
| Oct 7, 2026 | 1.35 | 1.40 | 1.33 | 1.34 | 62.50K |
| Oct 6, 2026 | 1.42 | 1.44 | 1.37 | 1.40 | 75.80K |
| Oct 5, 2026 | 1.43 | 1.44 | 1.38 | 1.41 | 37.30K |
| Oct 2, 2026 | 1.45 | 1.47 | 1.42 | 1.43 | 46.80K |
| Oct 1, 2026 | 1.47 | 1.50 | 1.40 | 1.40 | 140.70K |
| Sep 30, 2026 | 1.48 | 1.52 | 1.47 | 1.51 | 67.40K |
| Sep 29, 2026 | 1.41 | 1.47 | 1.40 | 1.47 | 32.70K |
| Sep 28, 2026 | 1.47 | 1.50 | 1.43 | 1.48 | 58.10K |
| Sep 25, 2026 | 1.45 | 1.48 | 1.41 | 1.47 | 37.70K |
| Sep 24, 2026 | 1.41 | 1.45 | 1.36 | 1.43 | 68.80K |
| Sep 23, 2026 | 1.50 | 1.59 | 1.41 | 1.44 | 169.80K |
| Sep 22, 2026 | 1.53 | 1.62 | 1.53 | 1.56 | 76.30K |
| Sep 21, 2026 | 1.53 | 1.55 | 1.47 | 1.51 | 88.90K |
About Cellectis
Cellectis (CLLS) is listed on the Nasdaq and classified by the SEC under βBiological Products, (No Diagnostic Substances)β. Its business address is in PARIS, LLE-DE-FRANCE. State of incorporation: France. Fiscal year ends December 31. SEC CIK 1627281.
CLLS board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| No Form 3/4/5 filings by this group in the last 12 months. | ||
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CLLS financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
CLLS earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Biological Products, (No Diagnostic Substances)
Moderna (MRNA)Amgen (AMGN)Gilead Sciences (GILD)Twist Bioscience (TWST)Revolution Medicines (RVMD)Argenx Se (ARGX)Kodiak Sciences (KOD)Greenland Mines (GRML)Halozyme Therapeutics (HALO)Biogen (BIIB)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CLLS
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.